Atorvastatin is a statin medication that inhibits HMG-CoA reductase, the rate-limiting enzyme in cholesterol production. This action significantly lowers LDL cholesterol levels, a primary causal factor in atherosclerosis. Its healthspan relevance is derived from its profound, evidence-backed ability to reduce the risk of major adverse cardiovascular events like heart attacks and strokes, which are leading causes of age-related mortality and morbidity.
Verdict
A foundational tool for managing cardiovascular risk via LDL reduction.
HEALTHSPAN IMPACT
High Value
RISK LEVEL
Moderate
EVIDENCE GRADE
A
MONTHLY COST
$5 - $20
Protocol
- Daily dosages of 10-20 mg are common for primary prevention of cardiovascular disease.
Flags
- Requires a prescription and medical supervision.
- Potential for muscle pain (myalgia) or, rarely, rhabdomyolysis.
- Associated with a small increased risk of developing type 2 diabetes.
- Interacts with grapefruit juice and drugs that inhibit the CYP3A4 enzyme.
- Regular blood tests are required to monitor lipid levels and liver function.